$96.46
0.99% today
Nasdaq, Apr 03, 06:47 pm CET
ISIN
US5165441032
Symbol
LNTH

Lantheus Holdings Inc Stock price

$97.42
+2.56 2.70% 1M
-7.76 7.38% 6M
+7.96 8.90% YTD
+38.55 65.48% 1Y
+40.71 71.79% 3Y
+86.26 772.94% 5Y
+90.65 1,339.00% 10Y
Nasdaq, Closing price Wed, Apr 02 2025
-0.51 0.52%
ISIN
US5165441032
Symbol
LNTH
Sector

Key metrics

Market capitalization $6.67b
Enterprise Value $6.38b
P/E (TTM) P/E ratio 22.28
EV/FCF (TTM) EV/FCF 13.00
EV/Sales (TTM) EV/Sales 4.16
P/S ratio (TTM) P/S ratio 4.35
P/B ratio (TTM) P/B ratio 6.35
Revenue growth (TTM) Revenue growth 18.32%
Revenue (TTM) Revenue $1.53b
EBIT (operating result TTM) EBIT $445.87m
Free Cash Flow (TTM) Free Cash Flow $490.79m
Cash position $912.81m
EPS (TTM) EPS $4.37
P/E forward 17.80
P/S forward 4.19
EV/Sales forward 4.01
Short interest 12.42%
Show more

Is Lantheus Holdings Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Lantheus Holdings Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Lantheus Holdings Inc forecast:

12x Buy
92%
1x Hold
8%

Analyst Opinions

13 Analysts have issued a Lantheus Holdings Inc forecast:

Buy
92%
Hold
8%

Financial data from Lantheus Holdings Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,534 1,534
18% 18%
100%
- Direct Costs 546 546
22% 22%
36%
988 988
17% 17%
64%
- Selling and Administrative Expenses 310 310
43% 43%
20%
- Research and Development Expense 168 168
116% 116%
11%
510 510
8% 8%
33%
- Depreciation and Amortization 65 65
8% 8%
4%
EBIT (Operating Income) EBIT 446 446
10% 10%
29%
Net Profit 312 312
4% 4%
20%

In millions USD.

Don't miss a Thing! We will send you all news about Lantheus Holdings Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Lantheus Holdings Inc Stock News

Neutral
GlobeNewsWire
2 days ago
BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced that it has completed its previously announced acquisition of Evergreen Theragnostics, Inc. (“Evergreen”), a ...
Positive
Seeking Alpha
27 days ago
Lantheus Holdings, Inc.'s stock has surged 55% since my last “Buy” rating, driven by strong revenue growth from Pylarify and Definity, and a profitable business model. Strategic acquisitions, including Life Molecular Imaging and Evergreen Theragnostics, have diversified Lantheus' pipeline, targeting new markets like Alzheimer's diagnostics and oncology therapeutics. Pylarify's potential patent ...
Neutral
The Motley Fool
about one month ago
Lantheus Holdings (LNTH -1.07%) held its fourth-quarter and full-year 2024 earnings call on Feb. 26, 2025, highlighting achievements in its radiopharmaceutical portfolio and announcing strategic transactions.
More Lantheus Holdings Inc News

Company Profile

Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. The firm operates through the following geographical segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sells its products to radio pharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 1956 and is headquartered in North Billerica, MA.

Head office United States
CEO Brian Markison
Employees 808
Founded 1956
Website www.lantheus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today